Abstract:Introduction: Patients with oligometastases are candidates for targeted therapy (1) , such as SABR. This allows delivery of biologically more potent dose, which may provide better local control and is advantageous for these patients (2). A disadvantage of SABR however is the lengthy time to deliver each high dose treatment (3). Clinicians currently supervise treatment delivery but this is insufficient use of a clinician's time (4). With SABR treatments likely to increase over coming years implementation of a R… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.